Skip to content

Discordant fatty acid profile drives residual inflammatory risk in metabolically vulnerable patients with low atherogenic lipoprotein burden.

Aug 2026 · Atherosclerosis · Vol 421, pp. 121885 · 0 citations · 36 references
Medicine

TL;DR

A latent fatty acid phenotype defined by omega-3 depletion and elevated omega-6/omega-3 ratio was associated with structural plaque vulnerability despite favorable atherogenic lipoprotein levels.

Abstract

Background

AND

Aims

Despite effective LDL-cholesterol reduction, residual cardiovascular risk persists. We investigated whether a specific fatty-acid phenotype predicts structural plaque instability and cardiovascular events independent of lipoprotein burden.

Methods

This multi-cohort study integrated a clinical discovery cohort (n = 201, GC-MS profiling) with the UK Biobank validation cohort (n = 263,481, NMR profiling). Unsupervised clustering derived fatty-acid phenotypes. Structural vulnerability was assessed via optical coherence tomography (OCT) in 138 patients. The primary endpoint was MACE (cardiovascular death, non-fatal MI, stroke).

Results

Two phenotypes emerged: Phenotype B, characterized by omega-3 depletion. Paradoxically, despite lower LDL-cholesterol (2.7 vs 3.0 mmol/L; p = 0.050) and triglycerides (1.5 vs 2.0 mmol/L; p = 0.041), Phenotype B exhibited significantly thinner fibrous caps (68.0 vs 94.2 μm; p = 0.003) and higher thin-cap fibroatheroma prevalence (49.0% vs 20.0%; p = 0.002) on OCT. In the UK Biobank, Phenotype B was associated with increased MACE risk in participants aged >60 years (HR 1.16; 95% CI 1.12-1.21; p < 0.001). In fully adjusted models, the hazard ratio was 1.12 (95% CI 1.08-1.16; p < 0.001), with 72% of excess risk mediated through glycemic, inflammatory, and adiposity pathways.

Conclusions

A latent fatty acid phenotype defined by omega-3 depletion and elevated omega-6/omega-3 ratio was associated with structural plaque vulnerability despite favorable atherogenic lipoprotein levels. In the UK Biobank, this phenotype was independently associated with increased MACE, most pronounced in participants aged 60 years and older. These observational findings warrant prospective validation.

View source

Similar papers

Open access Aug 2026

Beyond lipids: a precision prevention blueprint for China's residual risk

International recommendations with current Chinese practice are compared, barriers related to infrastructure, safety, education, standardization, and evidence localization are analyzed, and a multimodal implementation framework for residual-risk assessment is proposed.

Ming Chi, Tao-Ming Qian, Ji-Rong Zhang et al. · 0 citations
Sep 2026

Metabolic obesity phenotypes and degenerative valvular heart disease: A cohort study.

Obesity is persistently associated with increased aortic valve pathology risk, indicating that MHO is not entirely benign, and the need to integrate weight management with metabolic health optimization for VHD prevention.

Zhi-Xin Yan, Shuang Bing, Yi Gong et al. · 0 citations
Open access Aug 2026

Circulating lipids, lipoproteins, and the risk of idiopathic pulmonary fibrosis: a cohort study and genetic analysis

Triangulating evidence across approaches, Mendelian randomization analyses supported inverse associations of genetically predicted total cholesteryl esters and sphingomyelins with IPF risk, and highlights cholesterol and sphingolipid metabolism as potential contributors to IPF susceptibility.

Jiahao Zhu, Yu-Hao Shen, Zhe-An Yan et al. · 0 citations
Open access Sep 2026

Atherogenic Index of Plasma Across the Angiographic Spectrum of Coronary Stenosis: Implications for Risk Stratification

Objective: The atherogenic index of plasma (AIP), derived from the logarithmic ratio of triglycerides to high-density lipoprotein cholesterol, has been proposed as a marker of atherogenic lipid burden. Although previous studies have linked AIP to coronary artery disease, its association with progressively increasing an...

M. Savcılıoğlu, E. Vuruşkan, İ. Düzen et al. · 0 citations
Open access Aug 2026

Hepatic Steatosis and Low‐Density Lipoprotein Cholesterol Response After Statin Initiation: A Prospective Cohort Analysis

The association between hepatic steatosis and poorer LDL-C response to statins, if any, is not clinically significant and patients with hepatic steatosis are recommended to receive a standard statin dose according to clinical indications.

Kristopher Cho-Hei Lau, V. W. Wong, A. P. Kong et al. · 0 citations
Review Open access Sep 2026

Cardiometabolic and Psychobehavioral Phenotypes Define Cardiovascular Risk Heterogeneity in Rheumatoid Arthritis

Among adults with rheumatoid arthritis (RA), distinct data-driven phenotypes were identified based on combined patterns of metabolic, inflammatory, renal, behavioral, and psychosocial factors, with differing burdens of prevalent cardiovascular disease (CVD).

S. Jahan, A. Akter, S. Hossain et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.